• Amsterdam JD, Kaplan M, Potter L, Bloom L, Rickels K (1986) Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder. Psychopharmacology 88:484–488

  Google Scholar 

• Dunner D, Myers J, Khan A, Avery D, Ishiki D, Pyke R (1987) Adinazolam — a new antidepressant: findings of a placebocontrolled, double-blind study in outpatients with major depression. J Clin Psychopharmacol 7:170–172

  Google Scholar 

• Fleishaker JC, Phillips JP, Smith TC, Smith RB (1989) Multiple dose pharmacokinetics and pharmacodynamics of adinazolam in elderly subjects. Pharm Res (in press)

• Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd ed. Dekker, New York

  Google Scholar 

• Kroboth PD, Smith RB, Erb RJ (1988) Tolerance to alprazolam after intravenous bolus and continuous infusion: psychomotor and EEG effects. Clin Pharmacol Ther 43:270–277

  Google Scholar 

• Lahti A, Sethy VH, Barsuhn C, Hester JB (1983) Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine. Neuropharmacology 22:1277–1282

  Google Scholar 

• Peng GW, Todd WM, Rykert UM, Stryd RP, Pyke RE (1986) Dose proportionality of adinazolam mesylate (Deracyn^®). Pharm Res [Suppl]3:108s

• Randt CT, Brown ER (1983) Randt memory test administration manual. Life Science Associates, Bayport, New York

  Google Scholar 

• Sethy VH, Collins RJ, Daniels EG (1984) Determination of biological activity of adinazolam and its metabolites. J Pharm Pharmacol 36:546–548

  Google Scholar 

• Sethy VH, Francis JW, Day JS (1986) The effect of proadifen on the metabolism of adinazolam. J Pharm Pharmacol 38:631–632

  Google Scholar 

• Smith RB, Kroboth PD (1987) Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects. Psychopharmacology 93:105–112

  Google Scholar 

• Smith RB, Kroboth PD, Vanderlugt JT, Phillips JP, Juhl RP (1984) Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration. Psychopharmacology 84:452–456

  Google Scholar 

• Smith RB, Kroboth PD, Varner PD (1987) Pharmacodynamics of triazolam after intravenous administration. J Clin Pharmacol 27:971–979

  Google Scholar 

• Wagner JG, Rogge MC, Natale RB, Albert KS, Szpunar GJ (1987) Single dose and steady-state pharmacokinetics of adinazolam after oral administration to man. Biopharm Drug Dispos 8:405–425

  Google Scholar 

• Wechsler D (1955) A manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, New York

  Google Scholar 

• Weiss M (1988) A general model of metabolite kinetics following intravenous and oral administration of the parent drug. Biopharm Drug Dispos 9:159–176

  Google Scholar 

• Ziegler WH, Schalch E, Leishman B, Eckert M (1980) Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites. Br J Clin Pharmacol 16:63S-69S

  Google Scholar 

Download references